NCT05004636View on ClinicalTrials.gov

Adductor Canal Blocks With Bupivacaine and Magnesium After Same-day Discharge Total Knee Arthroplasty Improve Post-operative Pain Relief and Decrease Opioid Consumption: a Prospective Randomized Controlled Trial

NACompletedINTERVENTIONAL
Enrollment

119

Participants

Timeline

Start Date

August 5, 2020

Primary Completion Date

May 29, 2021

Study Completion Date

May 29, 2021

Conditions
Post-operative Pain, Acute
Interventions
DRUG

Adding Magnesium as an adjuvant to the adductor canal Block (ACB) for same-day discharge total knee arthroplasty

Post-operatively all patients will have an ultrasound-guided adductor canal block (ACB) with 30cc of 0.25% bupivacaine. Half of the patients (selected randomly using random number table) will receive 150mg of magnesium sulfate (0.3mL) in the block and the other half will receive 0.3 mL of saline in the block.

Trial Locations (1)

48341

St. Joseph Mercy Oakland Hospital, Pontiac

All Listed Sponsors
lead

Wayne State University

OTHER

NCT05004636 - Adductor Canal Blocks With Bupivacaine and Magnesium After Same-day Discharge Total Knee Arthroplasty Improve Post-operative Pain Relief and Decrease Opioid Consumption: a Prospective Randomized Controlled Trial | Biotech Hunter | Biotech Hunter